Dermatologicals in Colombia

 Published On: Oct, 2017 |    No of Pages: 20 |  Published By: Euromonitor | Format: PDF
Request Free Sample
Consumersí increasing confidence in using OTC dermatologicals to treat minor ailments, along with less social stigma surrounding antifungal products, continued to have a positive impact on category sales in 2017. Dermatologicals recorded further solid growth, albeit slower than the review period average, with this being mainly due to the weak economic climate and a rise in value-added tax, which forced many Colombians to rein in their spending by reducing their purchases of non-basic goods or sw...

Dermatologicals in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the marketís major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Headlines
Prospects
Category Growth Driven by Antifungals
Mixed Performances From Other Dermatological Categories
Competitive Landscape
Foreign Companies Lead the Way
Bayer De Colombia Loses Share As Sanofi-aventis Pharma Grows
Private Label and Generics
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2012-2017
Table 2 Sales of Dermatologicals by Category: % Value Growth 2012-2017
Table 3 NBO Company Shares of Dermatologicals: % Value 2013-2017
Table 4 LBN Brand Shares of Dermatologicals: % Value 2014-2017
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2014-2017
Table 6 Forecast Sales of Dermatologicals by Category: Value 2017-2022
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2017-2022
Executive Summary
Consumer Health Maintains Positive Growth in 2017 Amidst An Economic Slowdown
Growing Self-medication Trend Supported by Switches
Foreign Manufacturers Command A Major Share of Value Sales
Chemists/pharmacies Remains the Leading Distribution Channel for Consumer Health
Increasing Awareness of Self-care and the Ageing Population To Shape Future Sales
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 9 Life Expectancy at Birth 2012-2017
Market Data
Table 10 Sales of Consumer Health by Category: Value 2012-2017
Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches 2016-2017
Sources
Summary 2 Research Sources
If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.